Profile
Martin Erixon formerly worked at Hamlet BioPharma AB, as Chief Executive Officer from 2022 to 2023, Hamlet BioPharma AB, as Chief Executive Officer from 2023 to 2025, Gambro AB, as Manager-Research & Development Project, and Tetra Pak AB, as Manager-Research & Development Project from 2011 to 2022.
Mr. Erixon received his doctorate degree in 2007 from the University of Lund.
Former positions of Martin Erixon
| Companies | Position | End |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Chief Executive Officer | 18/02/2025 |
| HAMLET PHARMA AB (PUBL) | Chief Executive Officer | 01/10/2023 |
Tetra Pak AB
Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products | Corporate Officer/Principal | 01/06/2022 |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Corporate Officer/Principal | - |
Training of Martin Erixon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetra Pak AB
Tetra Pak AB Pulp & PaperProcess Industries Manufactures laminated paperboard materials and related packaging products | Process Industries |
Hamlet BioPharma AB
Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
- Stock Market
- Insiders
- Martin Erixon
















